Novel Leu-Val Based Dipeptide as Antimicrobial and Antimalarial Agents: Synthesis and Molecular Docking

• Published in: Frontiers in chemistry 2020-11, Vol.8, p.583926-583926
• Main Authors: Ezugwu, James A, Okoro, Uchechukwu C, Ezeokonkwo, Mercy A, Bhimapaka, China R, Okafor, Sunday N, Ugwu, David I, Ekoh, Ogechi C, Attah, Solomon I
• Format: Article
• Language: English
• Subjects: antimalarial; antimicrobial; benzenesulfonamide; Chemistry; in silico studies; Leu-Val dipeptide
• ISSN: 2296-2646; 2296-2646
• DOI: 10.3389/fchem.2020.583926

The increase of antimicrobial resistance (AMR) and antimalarial resistance are complex and severe health issues today, as many microbial strains have become resistant to market drugs. The choice for the synthesis of new dipeptide-carboxamide derivatives is as a result of their wide biological properties such as antimicrobial, anti-inflammatory, and antioxidant activities. The condensation reaction of substituted benzenesulphonamoyl pentanamides with the carboxamide derivatives using peptide coupling reagents gave targeted products ( ). The antimalarial and antibacterial studies showed good interactions of the compounds with target protein residues and a higher dock score in comparison with standard drugs. In the study, compound was the most potent antimalarial agent with 61.90% inhibition comparable with 67% inhibition for Artemisinin. In the antimicrobial activity, compounds and (MIC 1.2 × 10 M and 1.1 × 10 M) were most potent against ; compound , , and with MIC 6.0 × 10 M, 5.7 × 10 M, and 6.5 × 10 M, respectively, were the most active against ; compound (MIC 9.5 × 10 M) was most active against while , and were the most active against . Compounds and (MIC 1.3 × 10 M) each were the most active against , while compound (MIC 1.3 × 10 M) was most active against .